Adjuvance Technologies Announces First Clinical Results of its Next Generation Saponin Adjuvant
Adjuvance Technologies, a member of Bio Nebraska, announced positive results in the first clinical trial of its adjuvant TQL-1055.
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
GRAIL, a member of Bio Nebraska, has been acquired by Illumina, the global leader in DNA sequencing. GRAIL will continue to operate as a separate company.
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer, a member of Bio Nebraska, and BioNTech announced U.S. FDA approval of their COVID-19 vaccine that has been available for emergency use since December 2020.
U.S. Rep. Don Bacon Receives 2021 Champion of Health Care Innovation Award
Bio Nebraska partnered with the ALSIC to present the 2021 Champion of Health Care Innovation Award to Rep. Don Bacon.
Welcome Interstates
Bio Nebraska welcomes new member, Interstates!
Novozymes to invest $316 million in Blair
Novozymes, a member of Bio Nebraska, announced today that they have committed to a $316 million investment in Blair, Neb. to produce plant-based products.
Member Spotlight: Thyreos
Our August Member Spotlight features Thyreos, a human and animal health vaccine company. We talked to Eric Zeece, Thyreos’ CEO, about the seven-month-old company’s technology, its Nebraska-based partners, and the important impact its vaccines can have on human and animal health.
Implant shows extreme promise for regenerating bone
Researchers at UNMC and the UNL, both members of Bio Nebraska, have designed an implant that has the potential to repair bone damage.
Welcome Lab Crafters
Bio Nebraska welcomes new member, Lab Crafters!
Lincoln pharmacy veteran swings for the fences with new venture
Staska Pharmaceuticals, a member of Bio Nebraska, was featured in an article by Matt Olberding for the Lincoln Journal Star.